Shares of drug firm Neuland Laboratories rose nearly 6 percent on January 22 after the company announced that its board of directors approved capital expenditures totalling Rs 342 crore for capacity expansion at its facilities in Telangana. At 11:45 AM, shares of Neuland Laboratories were trading 5 percent higher at Rs 13,812.